10年试点方案提议为活肾捐赠者提供50 000美元的税收减免,以解决美国肾短缺问题。 10-year pilot program proposes $50,000 tax credit for living kidney donors to address US kidney shortage.
美国面临严重的肾脏短缺,超过90,000人等待移植,每月约有1,000人从名单上除名。 The US faces a severe kidney shortage, with over 90,000 people waiting for transplants and around 1,000 removed from the list each month. 作为回应，支持新联邦立法的联盟 Waitlist Zero 提出了《终止肾脏死亡法案》，这是一项为期 10 年的试点计划，为向全国候补名单上的匿名接受者捐献肾脏的人提供 50,000 美元的可退还税收抵免，分五年分配。 In response, Waitlist Zero, a coalition supporting new federal legislation, has proposed the End Kidney Deaths Act, a 10-year pilot program offering a refundable $50,000 tax credit spread over five years to people who donate a kidney to an anonymous recipient on the national waitlist. 该法案旨在激励活肾捐赠者,增加可供移植的肾数量,有可能挽救数千人的生命。 The bill aims to incentivize living kidney donors and increase the number of available kidneys for transplant, potentially saving thousands of lives. 一些人认为,提供器官付款可能导致非法器官贸易,而另一些人则认为,这项提议可大大增加肾的可用性。 Some argue that offering payment for organs could lead to an illicit organ trade, while others believe the proposal could significantly increase kidney availability.